Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...

Doctors have now used a gene-edited pig liver to keep a human alive, not as a thought experiment in a lab but as a real ...

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Every face is unique. Genetics helps to determine our features, but sometimes genes have errors which, in early fetal ...

There may be good reasons to object to using animals as living organ factories, including welfare concerns. But the rationale ...

Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems, has announced the publication of a new study in Nature Biomedical Engineering, titled "Spatial profiling of gene editing by ...

Scientists at Cincinnati Children's have taken a key early step in understanding why some people born with the rare disease ...

The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a potential one-and-done treatment for alpha-1 antitrypsin deficiency.

Health Canada has indefinitely suspended a proposed update to the novel food policy governing foods derived from cloned ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.